Hendrik Laue1,
Anja Hennemuth1, Volker Diehl1,2, Markus Thorsten Harz1,
Horst Karl Hahn1, Heinz-Otto Peitgen1
1Fraunhofer MEVIS,
The
consensus on diagnosis of breast cancer with DCE-MRI is the use of sequences
with high spatial and low temporal resolution, because of the in
inhomogeneous distribution of pharmacokinetic properties in the tumor and the
requirement to detect small lesions. The diagnostic in breast MRI today is
therefore based on simple curve shapes rather than pharmacokinetic modeling.
In this work, some pharmacokinetic modeling of contrast arrival time (CAT)
and variation of low temporal resolution are carried out to identify pitfalls
in the application and to identify techniques beneficial for the diagnostic
performance of breast MRI.